NCT05228509 (Portalflow) is a clinical trial in Cirrhosis Portal, sponsored by Peter atef.

Who is sponsoring NCT05228509?

NCT05228509 is sponsored by Peter atef.

What condition does NCT05228509 study?

NCT05228509 studies Cirrhosis Portal.

Is NCT05228509 still recruiting?

NCT05228509 is currently status unknown. Last updated 18 January 2024.

Last reviewed 2024-01-18 · How we verify

NCT05228509: Portalflow

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Status unknown Last updated 18 January 2024

What this trial tests

trial in Cirrhosis Portal in 75 participants. Status unknown.

Timeline

4 May 2021

Primary endpoint
2 December 2024

30 December 2024

Quick facts

Lead sponsor	Peter atef
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	75
Start date	4 May 2021
Primary completion	2 December 2024
Estimated completion	30 December 2024
Sites	2 locations across Egypt

Conditions studied

Cirrhosis Portal — all drugs for Cirrhosis Portal →

Sponsor

Peter atef

Who can join

Eligibility, any sex, with Cirrhosis Portal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Portal vein flow velocity as screening tool for prediction of oesophageal varices in cirrhotic patient without upper endoscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cirrhosis Portal

Currently open trials in the same condition.

NCT05597488 — EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endosc · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05228509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peter atef
Last refreshed: 18 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05228509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing